This afternoon we watched Everest Re drop -2.0% to a price of $337.56 per share. The mid-cap Reinsurance company is now trading -13.04% below its average target price of $388.17. Analysts have set target prices ranging from $358 to $419 per share for Everest Re, and have given the stock an average rating of buy.
The stock has a very low short interest at 1.5%, and a short ratio of 1.49. The company's insiders own 1.57% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 96.6% of Everest Re's shares being owned by this investor type.
Institutions Invested in Everest Re
| Holder | Shares | Date Reported | Percentage | Value |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 4,906,545 | 2022-09-29 | 13% | $1,656,277,874 |
| Blackrock Inc. | 2,811,152 | 2022-09-29 | 7% | $948,946,531 |
| Boston Partners | 2,587,523 | 2022-09-29 | 7% | $873,457,207 |
| State Street Corporation | 1,883,542 | 2022-09-29 | 5% | $635,817,859 |
| Franklin Resources, Inc. | 1,740,954 | 2022-09-29 | 4% | $587,685,141 |
| Champlain Investment Partners, LLC | 1,238,860 | 2022-09-29 | 3% | $418,195,778 |
| Victory Capital Management Inc. | 1,188,259 | 2022-09-29 | 3% | $401,114,652 |
| Massachusetts Financial Services Co. | 1,063,314 | 2022-09-29 | 3% | $358,937,593 |
| Altrinsic Global Advisors, LLC | 846,516 | 2022-09-29 | 2% | $285,754,175 |
| Geode Capital Management, LLC | 808,862 | 2022-09-29 | 2% | $273,043,503 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Everest Re.
